Aleva Neurotherapeutics
Pioneered directional deep brain stimulation DBS in Neuromodulation treatment of Parkinson's disease and essential tremor. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€29—44m (Dealroom.co estimates Dec 2019.)
Company register number CH-550.1.055.079-3
Lausanne Canton of Vaud (HQ)
Authorizing premium user...